{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:08:22Z","timestamp":1789398502101,"version":"build-2803163510"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Diabetic retinopathy (DR) and diabetic kidney disease (DKD) are major microvascular complications of diabetes that contribute substantially to visual disability and renal failure worldwide. Increasing evidence supports the concept of an \u201ceye\u2013kidney axis,\u201d whereby inflammatory and angiogenic dysregulation may drive parallel microvascular injury in the retina and kidney. The present systematic review aimed to synthesize current clinical evidence on the association between vitreous and serum cytokines and renal impairment in patients with DR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Following PRISMA guidelines, PubMed, Embase, and Web of Science were systematically searched (2005\u20132025). We included observational human studies investigating vitreous or serum cytokines in adult patients with clinically staged DR and their associations with renal function parameters, including estimated glomerular filtration rate (eGFR) and albuminuria. Data on study characteristics, cytokine profiles, renal metrics, and major findings were extracted. Study quality was assessed using the modified Newcastle\u2013Ottawa Scale. Due to heterogeneity in study design and outcomes, results were synthesized narratively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Seventeen eligible studies involving patients with type 1 and type 2 diabetes were included. Key cytokines assessed included angiogenic factors (VEGF, PlGF, ANGPTL2\/4) and inflammatory mediators (TNF-\u03b1, IL-6, IL-17A, MCP-1, sRAGE), measured predominantly using ELISA. Across studies, both vitreous and serum VEGF levels were consistently elevated in proliferative DR and showed significant associations with albuminuria and reduced eGFR. Pro-inflammatory cytokines including TNF-\u03b1, IL-17A, and progranulin correlated with DR severity and markers of DKD progression. Biomarkers such as s(P)RR, FABP4, and Ephrin-A1 also exhibited concordant trends with microvascular dysfunction in both organs. Overall, the compiled evidence indicates that inflammatory activation and aberrant angiogenesis are common molecular signatures linking retinal and renal microangiopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This systematic review supports the hypothesis that DR and DKD share overlapping inflammatory and angiogenic pathways, reflected by synchronized changes in vitreous and systemic cytokine levels. These findings highlight the potential of retinal-derived biomarkers for non-invasive risk stratification of DKD, and suggest therapeutic value in combined anti-inflammatory and anti-angiogenic strategies to protect eye\u2013kidney microvascular integrity. High-quality longitudinal and mechanistic studies are warranted to further establish causality within the eye\u2013kidney axis and translate biomarker-based surveillance into clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1767086","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:35:13Z","timestamp":1773207313000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Systematic review of ocular and circulatory cytokines linking diabetic retinopathy to kidney disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Yuyan","family":"Tang","sequence":"first","affiliation":[{"name":"College of Optometry and Ophthalmology, North Sichuan Medical College","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Clinical Medical College & Affiliated Hospital of Chengdu University","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The People\u2019s Hospital of Leshan","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"B1","first-page":"49","article-title":"Diabetic kidney disease: world wide difference of prevalence and risk factors","volume":"5","author":"Gheith","year":"2015","journal-title":"J Nephropharmacol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","article-title":"Diabetic vascular diseases: molecular mechanisms and therapeutic strategies","volume":"8","author":"Li","year":"2023","journal-title":"Signal Transduct Tgt Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.01.039","article-title":"The eye, the kidney, and cardiovascular disease: old concepts, better tools, and new horizons","volume":"98","author":"Farrah","year":"2020","journal-title":"Kidney Int"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.09.037","article-title":"Association of vitreous inflammatory factors with diabetic macular edema","volume":"116","author":"Funatsu","year":"2009","journal-title":"Ophthalmology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7754\/Clin.Lab.2019.190410","article-title":"Association between urinary levels of interleukin-6, interleukin-10 and tumor necrosis factor-alpha with glomerular and tubular damage indicators in patients with type 2 diabetes","volume":"65","author":"Sangoi","year":"2019","journal-title":"Clin Lab"},{"key":"B7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1186\/s12886-020-01580-0","article-title":"Plasma Ephrin-A1 level in a cohort of diabetic retinopathy patients","volume":"20","author":"Mao","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.984561","article-title":"The relationship between renal function and surgical outcomes of patients with proliferative diabetic retinopathy","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol Lausanne"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1040319","article-title":"The link between diabetic retinal and renal microvasculopathy is associated with dyslipidemia and upregulated circulating level of cytokines","volume":"10","author":"Chen","year":"2023","journal-title":"Front Public Health"},{"key":"B10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000317062","article-title":"Evaluation of the role of vascular endothelial growth factor in diabetic retinopathy","volume":"45","author":"Mahdy","year":"2011","journal-title":"Ophth Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.727407","article-title":"Correlations between different angiogenic and inflammatory factors in vitreous fluid of eyes with proliferative diabetic retinopathy","volume":"8","author":"Wu","year":"2021","journal-title":"Front Med Lausanne"},{"key":"B12","doi-asserted-by":"publisher","first-page":"12382","DOI":"10.1038\/s41598-021-91857-1","article-title":"Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy","volume":"11","author":"Itoh","year":"2021","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2174\/1573399815666190823155534","article-title":"Assessment of circulating biomarkers in relation to various stages of diabetic retinopathy in type 2 diabetic patients-A cross sectional study","volume":"16","author":"Mathala","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S27423","article-title":"Relationship between vitreous and serum vascular endothelial growth factor levels, control of diabetes and microalbuminuria in proliferative diabetic retinopathy","volume":"6","author":"Baharivand","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-016-0389-y","article-title":"Relationships between vitreous levels of soluble receptor for advanced glycation end products (sRAGE) and renal function in patients with diabetic retinopathy","volume":"37","author":"Katagiri","year":"2017","journal-title":"Int Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e000717","DOI":"10.1136\/bmjophth-2021-000717","article-title":"Pro-inflammatory cytokine profile is present in the serum of Mexican patients with different stages of diabetic retinopathy secondary to type 2 diabetes","volume":"6","author":"Quevedo-Mart\u00ednez","year":"2021","journal-title":"BMJ Open Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/357279","article-title":"Serum levels of progranulin are closely associated with microvascular complication in type 2 diabetes","volume":"2015","author":"Xu","year":"2015","journal-title":"Dis Markers"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e70033","DOI":"10.1002\/edm2.70033","article-title":"Associations between serum IL-17A, renal function and diabetic retinopathy in type 2 diabetes mellitus: evidence from a chinese han population","volume":"8","author":"Wang","year":"2025","journal-title":"Endocrinol Diabetes Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e0189696","DOI":"10.1371\/journal.pone.0189696","article-title":"Systemic factors related to soluble (pro)renin receptor in plasma of patients with proliferative diabetic retinopathy","volume":"12","author":"Hase","year":"2017","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3109\/09286586.2012.672619","article-title":"Cross-sectional associations of blood elements, clotting factors, nephropathy, and retinal outcomes in long duration type 1 diabetes","volume":"19","author":"Klein","year":"2012","journal-title":"Ophth Epidemiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-106295","article-title":"Serum and plasma levels of vascular endothelial growth factors in relation to quality of glucose control, biomarkers of inflammation, and diabetic nephropathy","volume":"48","author":"Hanefeld","year":"2016","journal-title":"Horm Metab Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"394206","DOI":"10.1155\/2014\/394206","article-title":"TNF-\u03b1 and microalbuminuria in patients with type 2 diabetes mellitus","volume":"2014","author":"Lampropoulou","year":"2014","journal-title":"J Diabetes Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4274\/jcrpe.3082","article-title":"The role of osteopontin in the pathogenesis and complications of type 1 diabetes mellitus in children","volume":"8","author":"Talat","year":"2016","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12964-022-01016-w","article-title":"Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction","volume":"21","author":"Xue","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B25","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12886-022-02439-2","article-title":"Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum - a systematic review","volume":"22","author":"Kuo","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.355743","article-title":"Inflammation in diabetic retinopathy: possible roles in pathogenesis and potential implications for therapy","volume":"18","author":"Tang","year":"2023","journal-title":"Neural Regener Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2016.10.020","article-title":"VEGF and the diabetic kidney: More than too much of a good thing","volume":"31","author":"Majumder","year":"2017","journal-title":"J Diabetes Comps"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.06.001","article-title":"AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions","volume":"833","author":"Sanajou","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.937999","article-title":"Neuroinflammation and neurodegeneration in diabetic retinopathy","volume":"14","author":"Bianco","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8546423","article-title":"Levels of inflammatory cytokines IL-1\u03b2, IL-6, IL-8, IL-17A, and TNF-\u03b1 in aqueous humour of patients with diabetic retinopathy","volume":"2018","author":"Feng","year":"2018","journal-title":"J Diabetes Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2020.100903","article-title":"Retinal capillary basement membrane thickening: Role in the pathogenesis of diabetic retinopathy","volume":"82","author":"Roy","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/948417","article-title":"Inflammatory cytokines in diabetic nephropathy","volume":"2015","author":"Donate-Correa","year":"2015","journal-title":"J Diabetes Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00568-2","article-title":"Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema","volume":"110","author":"Funatsu","year":"2003","journal-title":"Ophthalmology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2011.01.031","article-title":"Schlingemann RO, et\u00a0al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema","volume":"118","author":"Mitchell","year":"2011","journal-title":"Ophthalmology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000001493","article-title":"Systemic pharmacokinetics and pharmacodynamics of intravitreal aflibercept, bevacizumab, and ranibizumab","volume":"37","author":"Avery","year":"2017","journal-title":"Retina"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13301","article-title":"Heerspink HJL. Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers","volume":"20","author":"Dekkers","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2337\/db16-1364","article-title":"GLP-1R as a target for the treatment of diabetic retinopathy: friend or foe","volume":"66","author":"Sim\u00f3","year":"2017","journal-title":"Diabetes"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S40172","article-title":"Diabetic nephropathy - complications and treatment","volume":"7","author":"Lim","year":"2014","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw247","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction","volume":"38","author":"van Hout","year":"2017","journal-title":"Eur Heart J"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1767086\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:35:14Z","timestamp":1773207314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1767086\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":40,"alternative-id":["10.3389\/fendo.2026.1767086"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1767086","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"article-number":"1767086"}}